Abstract Search

ea0041ep210 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2016

Natural history and metabolic implications of the new hormone fibroblast growth factor 21 in uremic patients on peritoneal dialysis

Diez Juan J , Gonzalez Elena , Bajo Maria Auxiliadora , Peso Gloria Del , Grande Cristina , Rodriguez Olaia , Diaz-Almiron Mariana , Iglesiaas Pedro , Selgas Rafael

Background: Human fibroblast growth factor 21 (FGF21) is a new liver hormone that stimulate adipocyte glucose uptake and is involved in regulation of body fat.Objective: To define the natural history of FGF21 in peritoneal dialysis (PD) patients and analyze its relationship with glucose metabolism, peritoneal function, and residual renal function (RRF).Methods: We studied 48 uremic patients undergoing PD. Patients were evaluated at...

0 shares

ePoster

ea0037ep1030 | Thyroid (non-cancer) | ECE2015

Relationship between thyroid function tests and all-cause mortality in patients on peritoneal dialysis: a prospective analysis

Diez Juan J , Romero-Perez Sara , Bajo Maria A , Iglesias Pedro , Grande Cristina , Peso Gloria Del , Madero Rosario , Ossorio Marta , Selgas Rafael

Background: Alterations in thyroid function tests results in patients on peritoneal dialysis (PD) might represent a risk factor for cardiovascular disease (CVD) and mortality.Objective: To investigate the relationship of serum TSH, free thyroxine (FT4), and triiodothyronine (T3) concentrations with incident CVD and mortality in PD patients.Methods: Prospective study including all patients attending our PD unit...

0 shares

ePoster

Endocrine Abstracts

Natural history and metabolic implications of the new hormone fibroblast growth factor 21 in uremic patients on peritoneal dialysis

Relationship between thyroid function tests and all-cause mortality in patients on peritoneal dialysis: a prospective analysis

BiosciAbstracts